Recommended

Sarepta’s DMD drug Elevidys issued FDA label update
Rare disease gene therapy granted European first approval
Johnson & Johnson agrees $3bn oncology acquisition
European Commission grants EU first for J&J’s Simponi biosimilar
Researchers validate approach that supports animal-based pyrogen test replacement
ON DEMAND webinar: automating QC testing for radiopharmaceutical production
Insmed secures EU approval for Brinsupri (brensocatib)
Moderna invests over $140m to onshore mRNA medicine manufacturing in US
news

Auditing is theme for next BGMA Quality Forum

0
SHARES

Auditing will be a key theme of the British Generic Manufacturers Association’s (BGMA) next BGMA Quality Forum meeting on Wednesday, November 12th which is run in partnership with the MHRA.

The forum was launched earlier this year in conjunction with the UK’s medicines regulator in order to focus on issues and guidance relating to quality.

 

Reserve your FREE place

 


Address the time-to-result challenge posed by short shelf-life radiopharmaceuticals.

20 November 2025 | 3:00 PM GMT | FREE Virtual Panel Discussion

This webinar showcases the Growth Direct System; an RMM (Rapid Microbial Method) that improves on traditional membrane filtration, delivering increased accuracy, a faster time to result, enhanced data integrity compliance, and more control over the manufacturing process.

Key learning points:

  • Understand the benefits of full workflow microbiology quality control testing automation in radiopharmaceutical production
  • Learn about ITM’s implementation journey and considerations when evaluating the technology
  • Find out how the advanced optics and microcolony detection capabilities of Growth Direct® technology impact time to result (TTR).

Don’t miss your chance to learn from experts in the industry – Register for FREE

 

The group meets three times a year to share and discuss the latest information which impacts quality in the generics industry from auditing and inspections through to data integrity and issues surrounding API.

The next meeting will focus on a number of topics relating to audits looking at trends from inspections, effective practice, challenges and sharing information.

Paul Fleming, the BGMA’s Technical Director, said: “We have been very pleased with the response to our BGMA Quality Forum since we launched earlier this year.  Having a platform that manufacturers and the wider industry can share in partnership with our regulator is important as it allows information to be shared effectively.

“Within the UK, there is a very established and mature generics market and security of supply is paramount in order patients receive their medicines. Therefore anything we can do to promote quality and best practice is important for the continued sustainability of the industry and its supply chain.”

The forum is open to members and associate members of the BGMA and for further information please contact email [email protected]. Full information is also be available on the website www.britishgenerics.co.uk

Related topics

Related organisations

Related people

Share via
Share via